LyfeSci Research & Innovation Acquires Clinically Media

Healthly Acquires Lifestyle Medical (Non-Clinical Assets)

June 13, 2024

Healthcare Services

Healthly announced the acquisition of Lifestyle Medical's non-clinical assets and a management services partnership to operate the practice's non-clinical operations. Lifestyle Medical, a lifestyle-medicine primary care practice founded in 2015 with two Southern California locations, will provide clinical leadership while Healthly integrates the clinic model into its Medicare Advantage membership-based care.

MediSpend Acquires Real Life Sciences

January 27, 2025

Cloud & SaaS

MediSpend, a Susquehanna Growth Equity‑backed life sciences technology company, has acquired Real Life Sciences (RLS), a provider of advanced anonymization and redaction solutions for clinical trial data. The deal expands MediSpend's Governance, Risk and Compliance (GRC) capabilities—adding RLS Protect SaaS and expert anonymization services to support pharma, biotech and CRO clients with regulatory disclosure and participant privacy.

MRO Acquires Clinetic

November 18, 2025

Healthcare Services

MRO has acquired Clinetic, an AI-driven patient recruitment management platform that integrates with provider EHRs to identify and enroll patients for clinical trials. MRO plans to incorporate Clinetic’s software across its clinical data platform (including the Q-Centrix Research Network) to expand recruitment capacity, streamline enrollment, and enhance research capabilities for hospitals, health systems, and life sciences sponsors.

Discovery Life Sciences Acquires ReachBio Research Labs

April 11, 2023

Biotechnology

Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.

Velocity Clinical Research Acquires MedPharmics

September 7, 2022

Healthcare Services

Velocity Clinical Research, a portfolio company of GHO Capital, has acquired MedPharmics, a U.S.-based multi-site clinical research organization. The add-on expands Velocity's network by eight sites (bringing it to 40 locations), adds just over 100 employees, and improves access to diverse patient populations including African American and Native American communities.

TransPerfect Life Sciences Acquires LMK Clinical Research Consulting

December 6, 2021

Healthcare Services

TransPerfect Life Sciences has acquired LMK Clinical Research Consulting, a specialized provider of Trial Master File (TMF) document management, training and consulting services. The acquisition expands TransPerfect's TMF and eTMF capabilities and adds LMK's accredited TMF University training program to TransPerfect's life sciences offerings; financial terms were not disclosed.